Mohammad Hamid, MD
Contact Info
Office Hours
- Today
- 8:30AM-4:00PM
Mohammad Hamid, MD
About Mohammad Hamid, MD
A native of Montreal, Dr. Hamid is passionate about learning and has always been an exceptional student, being at the top of his class throughout his academic career. He completed his medical degree at the University of Montreal with excellence, and then he specialized in ophthalmology, where he completed a five-year residency program at the University of Sherbrooke. He also served as Chief Resident, where he was then assigned the responsibility of teaching ophthalmology to his more junior colleagues.
Dr. Hamid also completed a post-doctoral fellowship at the University of Montreal, and specialized in refractive surgery. He gained his experience working with one of the most recognized refractive surgeons in Canada, Dr. Michel Podtetenev, and joined the Invisia and PreciVision Clinic in 2015.
Dr. Hamid has performed over 10,000 intraocular surgeries. He has extensive knowledge in refractive surgery and specializes in complicated cases.
Dr Hamid is an active member of the ophthalmology community. He has had the opportunity to share his knowledge at some of the largest conferences in the industry such as the American Society of Cataract and Refractive Surgery, the American Glaucoma Society and the Canadian Glaucoma Society. He has published several peer-reviewed scientific articles, received several research grants for his work and continues to conduct clinical studies on the subject today.
Dr Hamid is a passionate teacher who regularly gives lectures to colleagues. He is a clinical assistant professor at the University of Sherbrooke where he trains residents of the University of Montreal and the University of Sherbrooke.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.